Abstract
Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Keywords: Protein folding, diseases, nano-fibrils
Current Proteomics
Title: Protein Nano-Fibrilar Structure and Associated Diseases
Volume: 7 Issue: 2
Author(s): Nandini Sarkar and Vikash Kumar Dubey
Affiliation:
Keywords: Protein folding, diseases, nano-fibrils
Abstract: Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Export Options
About this article
Cite this article as:
Sarkar Nandini and Kumar Dubey Vikash, Protein Nano-Fibrilar Structure and Associated Diseases, Current Proteomics 2010; 7 (2) . https://dx.doi.org/10.2174/157016410791330516
DOI https://dx.doi.org/10.2174/157016410791330516 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HSP27: Mechanisms of Cellular Protection Against Neuronal Injury
Current Molecular Medicine Inhibition of GSK3 Dependent Tau Phosphorylation by Metals
Current Alzheimer Research Cardioprotective Effects of Sour Cherry Seed Extract (SCSE) on the Hypercholesterolemic Rabbit Heart
Current Pharmaceutical Design Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews A Review of Clinical Pharmacokinetics and Pharmacodynamics of Galantamine, a Reversible Acetylcholinesterase Inhibitor for the Treatment of Alzheimer s Disease, in Healthy Subjects and Patients
Current Clinical Pharmacology CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease
Current Drug Targets Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions
Current Medicinal Chemistry subject Index To Volume 1
Current Drug Targets - CNS & Neurological Disorders The Role of Autophagy on the Survival of Dopamine Neurons
Current Topics in Medicinal Chemistry Synthesis of Highly Functionalised Dispiropyrrolidine Derivatives as Novel Acetylcholinesterase Inhibitors
Letters in Drug Design & Discovery Genome-Wide Association Studies: Is there a Genotype for Cognitive Decline in Older Persons with Type 2 Diabetes?
Current Pharmaceutical Design Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease
Current Alzheimer Research Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders
CNS & Neurological Disorders - Drug Targets Evaluation of In Vivo and In Vitro Antimicrobial Activities of a Selective Serotonin Reuptake Inhibitor Sertraline Hydrochloride
Anti-Infective Agents Imidazoline Receptor Agonists for Managing Hypertension May Hold Promise for Treatment of Intracerebral Hemorrhage
Current Molecular Medicine Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis
Current Molecular Medicine Comparative Evaluation of Ethanolic Extracts of Bacopa monnieri, Evolvulus alsinoides, Tinospora cordifolia and their Combinations on Cognitive Functions in Rats
Current Aging Science Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology The Role of Renal Nerve Ablation for the Management of Resistant Hypertension and other Disease Conditions: Benefits and Concerns
Current Vascular Pharmacology